Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. (2023)

First Author: Beishuizen A
Attributed to:  Clonal heterogeneity and therapy resistance in Burkitt lymphoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3026(22)00374-x

PubMed Identifier: 36858678

Publication URI: http://europepmc.org/abstract/MED/36858678

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Haematology

Issue: 3

ISSN: 2352-3026